GB202209866D0 - Cross linked collagen type v assay - Google Patents

Cross linked collagen type v assay

Info

Publication number
GB202209866D0
GB202209866D0 GBGB2209866.9A GB202209866A GB202209866D0 GB 202209866 D0 GB202209866 D0 GB 202209866D0 GB 202209866 A GB202209866 A GB 202209866A GB 202209866 D0 GB202209866 D0 GB 202209866D0
Authority
GB
United Kingdom
Prior art keywords
assay
collagen type
cross linked
linked collagen
cross
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2209866.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordic Bioscience AS
Original Assignee
Nordic Bioscience AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordic Bioscience AS filed Critical Nordic Bioscience AS
Priority to GBGB2209866.9A priority Critical patent/GB202209866D0/en
Publication of GB202209866D0 publication Critical patent/GB202209866D0/en
Priority to PCT/EP2023/068548 priority patent/WO2024008796A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
GBGB2209866.9A 2022-07-05 2022-07-05 Cross linked collagen type v assay Ceased GB202209866D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2209866.9A GB202209866D0 (en) 2022-07-05 2022-07-05 Cross linked collagen type v assay
PCT/EP2023/068548 WO2024008796A1 (en) 2022-07-05 2023-07-05 Cross linked collagen type v assay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2209866.9A GB202209866D0 (en) 2022-07-05 2022-07-05 Cross linked collagen type v assay

Publications (1)

Publication Number Publication Date
GB202209866D0 true GB202209866D0 (en) 2022-08-17

Family

ID=82802684

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2209866.9A Ceased GB202209866D0 (en) 2022-07-05 2022-07-05 Cross linked collagen type v assay

Country Status (2)

Country Link
GB (1) GB202209866D0 (en)
WO (1) WO2024008796A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9404932B2 (en) * 2007-11-05 2016-08-02 Nordic Bioscience A/S Pathology biomarker assay

Also Published As

Publication number Publication date
WO2024008796A1 (en) 2024-01-11

Similar Documents

Publication Publication Date Title
GB202209866D0 (en) Cross linked collagen type v assay
EP3995826A4 (en) Biomaterial assay strip
GB202108802D0 (en) Collagen type XX assay
GB202011617D0 (en) Assay
GB202004195D0 (en) Type XIX collagen assay
GB202307576D0 (en) C3a1-hne assay
GB202301141D0 (en) Pro-c5 assay
GB202218042D0 (en) Pro-C9 assay
GB202215897D0 (en) Neostatin-14 assay
GB202213495D0 (en) Cilp-m assay
GB202203276D0 (en) Assay
GB201901710D0 (en) Collagen type 23 assay
GB202210527D0 (en) Collagen type VI alpha-6 assay
GB202301919D0 (en) Protein
GB202301933D0 (en) Protein
GB202312969D0 (en) Modified proteins
GB202201714D0 (en) Protein
GB202201715D0 (en) Protein
IL307174A (en) Assay
GB202119033D0 (en) Assay
GB202404192D0 (en) Pro-c12 assay
GB202404073D0 (en) Bigh3m-n assay
GB202117513D0 (en) Assay
GB202115077D0 (en) Assay
GB202115072D0 (en) Assay

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)